Type of skin lesions |
Number |
Percentag |
Scabies |
13 |
09.28 |
Papular Purpuric Erruptions |
13 |
09.28 |
Pyoderma |
12 |
08.57 |
Seborrhoic dermatitis |
07 |
05.00 |
Fungal skin infection |
05 |
03.57 |
Fungal nail infection |
03 |
02.12 |
Chicken pox |
04 |
02.85 |
Herpese zoster |
02 |
01.42 |
Cheloid |
02 |
01.42 |
Non-healing ulcer |
02 |
01.42 |
Molluscum contagiosum |
03 |
02.14 |
Opportunistic conditions |
1.5- 05 years |
05- 10 |
10- 15 |
Total |
Tuberculosis |
02 |
05 |
07 |
14 |
Rec.
Bact. pneumonia |
01 |
10 |
02 |
13 |
Rec.
Empyema thorasis |
00 |
03 |
00 |
03 |
Rec.
Diarrhoea |
06 |
15 |
05 |
26 |
Skin
conditions |
14 |
24 |
28 |
66 |
Oropharyngeal
candidiasis |
06 |
02 |
02 |
10 |
Rec.UTI |
04 |
03 |
03 |
10 |
Rec.
Pyogenic meningitis |
02 |
00 |
01 |
03 |
CSOM |
06 |
04 |
07 |
17 |
Systemic.Viral
infection |
02 |
03 |
02 |
07 |
Cryptococcal
meningitis |
00 |
00 |
01 |
01 |
Pneumocystis
carinii pneumonia |
00 |
00 |
01 |
01 |
HIV
Encephalopathy |
00 |
00 |
01 |
01 |
Non
Hodgekins Lymphoma |
01 |
00 |
00 |
01 |
WHO
Clinical and Immunological staging |
Tubercular |
Pyogenic |
Fungal |
Viral |
Clinical
stage I |
00 |
02 |
00 |
01 |
Immunological
stage I |
00 |
14 |
02 |
10 |
Clinical
stage II |
01 |
21 |
11 |
12 |
Immunological
stageII |
01 |
08 |
03 |
05 |
Clinical
stage III |
10 |
24 |
13 |
06 |
Immuno.stage
III |
08 |
17 |
11 |
02 |
Clinical stage IV |
03 |
03 |
04 |
01 |
Immuno. Stage IV |
05 |
12 |
10 |
03 |
Total |
14 |
51 |
26 |
20 |
UTI organism |
Age & sex 01.5-05 yr
(n-41) |
Age & sex 05-15 yr
(n-99) |
||||
F |
M |
T % |
F |
M |
T % |
|
E. Coli |
1 |
1 |
2 (4.88) |
1 |
2 |
3 (3.03) |
Kleibsella |
0 |
1 |
1 (2.44) |
0 |
2 |
2 (2.02) |
St . aureus |
0 |
1 |
1 (2.44) |
0 |
0 |
0 |
Trichomonas |
0 |
0 |
0 |
1 |
0 |
1 (1.01) |
Total |
1 |
3 |
4 (9.76) |
2 |
4 |
6 (6.06) |
Persistent
Diarrhoea organism |
Age & sex 01.5-05 yrs
(n-41) |
Age & sex 05-15 yrs
(n-99) |
||||
F |
M |
Total |
F |
M |
Total |
|
Giardia |
0 |
0 |
0 |
2 |
2 |
4 (4.04%) |
Kleibsella |
0 |
1 |
1 (2.44%) |
1 |
1 |
2 (2.02%) |
E
. coli |
0 |
2 |
2 (4.88%) |
1 |
0 |
1 (1.01%) |
Fungus
|
0 |
1 |
1(2.44%) |
0 |
2 |
2 (2.02%) |
Other
associated infections |
0 |
1 |
1 (2.44%) |
4 |
5 |
9 (9.09%) |
None
|
0 |
1 |
1(2.44%) |
1 |
1 |
2 (2.02%) |
Total |
0 |
06 |
06 (14.63%)) |
9 |
11 |
20 (20.20%) |